These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

676 related articles for article (PubMed ID: 16403930)

  • 1. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis.
    Bhatt DL; Steg PG; Ohman EM; Hirsch AT; Ikeda Y; Mas JL; Goto S; Liau CS; Richard AJ; Röther J; Wilson PW;
    JAMA; 2006 Jan; 295(2):180-9. PubMed ID: 16403930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence, recognition and treatment of cardiovascular risk factors in outpatients with atherothrombosis in Israel.
    Barski L; Porath A; Novack V; Jotkowitz A
    Isr Med Assoc J; 2007 May; 9(5):376-9. PubMed ID: 17591377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk profile and outcome of patients with abdominal aortic aneurysm in out-patients with atherothrombosis: data from the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
    Baumgartner I; Hirsch AT; Abola MT; Cacoub PP; Poldermans D; Steg PG; Creager MA; Bhatt DL;
    J Vasc Surg; 2008 Oct; 48(4):808-14. PubMed ID: 18639426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factor profile and treatment patterns of patients with atherothrombosis in Singapore: insight from the REACH Registry.
    Yeo TC; Chan YH; Low LP; Venketasubramanian N; Lim SC; Tay JC; Tan RS; Eng P; Lingamanaicker J;
    Ann Acad Med Singap; 2008 May; 37(5):365-71. PubMed ID: 18536821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis.
    Bhatt DL; Eagle KA; Ohman EM; Hirsch AT; Goto S; Mahoney EM; Wilson PW; Alberts MJ; D'Agostino R; Liau CS; Mas JL; Röther J; Smith SC; Salette G; Contant CF; Massaro JM; Steg PG;
    JAMA; 2010 Sep; 304(12):1350-7. PubMed ID: 20805624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year cardiovascular event rates in outpatients with atherothrombosis.
    Steg PG; Bhatt DL; Wilson PW; D'Agostino R; Ohman EM; Röther J; Liau CS; Hirsch AT; Mas JL; Ikeda Y; Pencina MJ; Goto S;
    JAMA; 2007 Mar; 297(11):1197-206. PubMed ID: 17374814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prior cardiovascular interventions are not associated with worsened clinical outcomes in patients with symptomatic atherothrombosis.
    Boden WE; Cherr GS; Eagle KA; Cannon CP; Califf RM; Hirsch AT; Alberts MJ; Criqui M; Creager MA; Massaro JM; D'Agostino RB; Steg PG; Bhatt DL;
    Crit Pathw Cardiol; 2010 Sep; 9(3):116-25. PubMed ID: 20802264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atherothrombosis and the management of the vulnerable vascular patient.
    Arora R; Rai F
    Am J Ther; 2009; 16(1):24-34. PubMed ID: 19114877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geographic differences in outcomes in outpatients with established atherothrombotic disease: results from the REACH Registry.
    Ducrocq G; Bhatt DL; Labreuche J; Corbalan R; Porath A; Gao R; Panchenko E; Liau CS; Ikeda Y; Goto S; Amarenco P; Steg PG
    Eur J Prev Cardiol; 2014 Dec; 21(12):1509-16. PubMed ID: 23965467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis.
    Kumbhani DJ; Steg PG; Cannon CP; Eagle KA; Smith SC; Hoffman E; Goto S; Ohman EM; Bhatt DL;
    Am J Med; 2013 Aug; 126(8):693-700.e1. PubMed ID: 23800583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional and practice variation in adherence to guideline recommendations for secondary and primary prevention among outpatients with atherothrombosis or risk factors in the United States: a report from the REACH Registry.
    Kumar A; Fonarow GC; Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Boden WE; Steg PG; Shao M; Bhatt DL; Cannon CP;
    Crit Pathw Cardiol; 2009 Sep; 8(3):104-11. PubMed ID: 19726929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of atherothrombosis and its treatment in Mexico: first-year data of the REACH Registry.
    Gaxiola E; Eng-Ceceña L; Ortiz-Galván F; Llamas-López L; Rangel-Guerra R; Alcocer-Gamba MA; Bhatt DL; Gabriel Steg P;
    Clin Cardiol; 2010 Jul; 33(7):445-51. PubMed ID: 20641123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factor profile and management of cerebrovascular patients in the REACH Registry.
    Röther J; Alberts MJ; Touzé E; Mas JL; Hill MD; Michel P; Bhatt DL; Aichner FT; Goto S; Matsumoto M; Ohman EM; Okada Y; Uchiyama S; D'Agostino R; Hirsch AT; Wilson PW; Steg PG;
    Cerebrovasc Dis; 2008; 25(4):366-74. PubMed ID: 18337635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of atherothrombotic risk factors in high-risk Canadian outpatients.
    Bell A; Hill MD; Herman RJ; Girard M; Cohen E;
    Can J Cardiol; 2009 Jun; 25(6):345-51. PubMed ID: 19536375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
    Cacoub PP; Abola MT; Baumgartner I; Bhatt DL; Creager MA; Liau CS; Goto S; Röther J; Steg PG; Hirsch AT;
    Atherosclerosis; 2009 Jun; 204(2):e86-92. PubMed ID: 19054514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Australians at risk: management of cardiovascular risk factors in the REACH Registry.
    Reid C; Nelson MR; Shiel L; Chew D; Connor G; DeLooze F
    Heart Lung Circ; 2008 Apr; 17(2):114-8. PubMed ID: 17931974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Underrecognition and undertreatment of atherothrombotic diseases: REACH Registry Taiwan baseline data.
    Cheng TJ; Hsieh YK; Ryu SJ; Lai WT; Lo HM; Sung ML; Tsao WL; Yip PK; Liau CS;
    J Formos Med Assoc; 2007 Jul; 106(7):548-57. PubMed ID: 17660144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. REACH: international prospective observational registry in patients at risk of atherothrombotic events. Results for the French arm at baseline and one year.
    Sabouret P; Cacoub P; Dallongeville J; Krempf M; Mas JL; Pinel JF; Priollet P; Steg G; Taminau D; Montalescot G;
    Arch Cardiovasc Dis; 2008 Feb; 101(2):81-8. PubMed ID: 18398391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events-study design.
    Ohman EM; Bhatt DL; Steg PG; Goto S; Hirsch AT; Liau CS; Mas JL; Richard AJ; Röther J; Wilson PW;
    Am Heart J; 2006 Apr; 151(4):786.e1-10. PubMed ID: 16569533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular ischemic event rates in outpatients with symptomatic atherothrombosis or risk factors in the united states: insights from the REACH Registry.
    Eagle KA; Hirsch AT; Califf RM; Alberts MJ; Steg PG; Cannon CP; Brennan DM; Bhatt DL;
    Crit Pathw Cardiol; 2009 Jun; 8(2):91-7. PubMed ID: 19417637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.